CASCINU, Stefano
CASCINU, Stefano
Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto
5-Fluorouracil pharmacogenomics: still rocking after all these years?
2011 M., Scartozzi; E., Maccaroni; R., Giampieri; M., Pistelli; A., Bittoni; M. D., Prete; R., Berardi; Cascinu, Stefano
9 Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER.
2010 Guarneri, Valentina; Frassoldati, A; Gebbia, V; Bisagni, G; Cavanna, L; Donadio, M; Lelli, G; Musolino, A; Colucci, G; Banna, Gl; Degli Esposti, R; Ferro, A; Grasso, F; Zamagni, C; Amadori, D; Aieta, M; Molino, A; Garrone, O; Aitini, E; Fornari, G; Cascinu, Stefano; Rossi, G; D'Amico, Roberto; Conte, Pierfranco
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
2014 Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)
2017 Gelsomino, Fabio; Bertolini, Federica; Luppi, Gabriele; Spallanzani, Andrea; Pettorelli, Elisa; Reggiani Bonetti, Luca; Meduri, Bruno; Manco, Gianrocco; Conte, Pierfranco; Cascinu, Stefano
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
2012 Campanati, A.; Berardi, R.; Onofri, A.; Pierantoni, C.; Conte, I.; Giuliodori, K.; Molinelli, E.; Marcucci, F.; Cascinu, Stefano; Offidani, A.
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
2015 de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T.
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.
2012 G., Gasparini; F., Torino; T., Ueno; Cascinu, Stefano; T., Troiani; A., Ballestrero; R., Berardi; J., Shishido; A., Yoshizawa; Y., Mori; S., Nagayama; P., Morosini; M., Toi
A randomized, double blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.
2013 P., Maison Blanche; J. B., Vermorken; T., Goksel; J., Machiels; S., Agarwala; S., Rottey; G., Daugaard; C., Volovat; M., Scheulen; L., Sengeløv; D., Grecea; A., Eniu; E., Jäger; E., Meiri; Cascinu, Stefano; D., Strumberg; G., Demir; M., Clemens; G., Pinotti; M., Nardi; T., Guthrie; E., Boelle; E., Magherini
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC)
2019 Salati, M.; Pipitone, S.; Rimini, M.; Gelsomino, F.; Casadei-Gardini, A.; Andrikou, K.; Schipilliti, F. M.; Cortesi, G.; Cassanelli, L.; Caffari, E.; Serra, F.; Ricciardolo, A.; De Ruvo, N.; Gelmini, R.; Cascinu, S.; Spallanzani, A.
Adjuvant chemotherapy in colon cancer: can we improve quality of care?
2013 Cascinu, Stefano
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.
2011 Scartozzi, M.; Loretelli, C.; Bearzi, I.; Mandolesi, A.; Galizia, E.; Onofri, A.; Pistelli, M.; Bittoni, A.; Berardi, R.; Cascinu, Stefano
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
2012 M., Scartozzi; R., Giampieri; E., Maccaroni; A., Mandolesi; L., Giustini; R., Silva; A., Zaniboni; T., Biscotti; S., Biagetti; E., Galizia; F., Loupakis; A., Falcone; I., Bearzi; Cascinu, Stefano
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.
2014 Pistelli, M; Caramanti, M; Biscotti, T; Santinelli, A; Pagliacci, A; De Lisa, M; Ballatore, Z; Ridolfi, F; Maccaroni, E; Bracci, R; Berardi, R; Battelli, N; Cascinu, Stefano
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
2016 Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Cascinu, Stefano; Gasparini, Giampietro; Lorusso, Vito; Ribatti, Domenico; Silvestris, Nicola
Angiogenetic pathway as a therapeutic target in renal cell carcinoma.
2012 M., Bianconi; M., Scartozzi; L., Faloppi; A., Bittoni; E., Maccaroni; R., Giampieri; M. D., Prete; L., Burattini; Cascinu, Stefano
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
2019 Marisi, Giorgia; Petracci, Elisabetta; Raimondi, Francesco; Faloppi, Luca; Foschi, Francesco Giuseppe; Lauletta, Gianfranco; Iavarone, Massimo; Canale, Matteo; Valgiusti, Martina; Neri, Luca Maria; Ulivi, Paola; Orsi, Giulia; Rovesti, Giulia; Vukotic, Ranka; Conti, Fabio; Cucchetti, Alessandro; Ercolani, Giorgio; Andrikou, Kalliopi; Cascinu, Stefano; Scartozzi, Mario; Casadei-Gardini, Andrea
Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials.
2013 Iacovelli, R; Altavilla, A; Procopio, G; Bracarda, S; Santoni, M; Cascinu, Stefano; Cortesi, E.
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality
2019 Malavasi, Vincenzo Livio; Fantecchi, Elisa; Gianolio, Laura; Pesce, Francesca; Longo, Giuseppe; Marietta, Marco; Cascinu, Stefano; Lip, Gregory Y. H.; Boriani, Giuseppe
Bone metastases- Pharmacological treatment
2010 Guarneri, Valentina; Bertolini, Federica; Cascinu, Stefano; T., Ibrahim
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival
2017 Ponti, Giovanni; Manfredini, Marco; Greco, Stefano; Pellacani, Giovanni; Depenni, Roberta; Tomasi, Aldo; Maccaferri, Monia; Cascinu, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil pharmacogenomics: still rocking after all these years? | 1-gen-2011 | M., Scartozzi; E., Maccaroni; R., Giampieri; M., Pistelli; A., Bittoni; M. D., Prete; R., Berardi; Cascinu, Stefano | |
| 9 Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER. | 1-gen-2010 | Guarneri, Valentina; Frassoldati, A; Gebbia, V; Bisagni, G; Cavanna, L; Donadio, M; Lelli, G; Musolino, A; Colucci, G; Banna, Gl; Degli Esposti, R; Ferro, A; Grasso, F; Zamagni, C; Amadori, D; Aieta, M; Molino, A; Garrone, O; Aitini, E; Fornari, G; Cascinu, Stefano; Rossi, G; D'Amico, Roberto; Conte, Pierfranco | |
| [11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas | 1-gen-2014 | Matteo, Santoni; Cristina, Nanni; Alessandro, Bittoni; Gabriele, Polonara; Alessandro, Paccapelo; Roberto, Trignani; Mariagrazia De, Lisa; Franco, Rychlicki; Luciano, Burattini; Rossana, Berardi; Stefano, Fanti; Cascinu, Stefano | |
| A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) | 1-gen-2017 | Gelsomino, Fabio; Bertolini, Federica; Luppi, Gabriele; Spallanzani, Andrea; Pettorelli, Elisa; Reggiani Bonetti, Luca; Meduri, Bruno; Manco, Gianrocco; Conte, Pierfranco; Cascinu, Stefano | |
| A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. | 1-gen-2012 | Campanati, A.; Berardi, R.; Onofri, A.; Pierantoni, C.; Conte, I.; Giuliodori, K.; Molinelli, E.; Marcucci, F.; Cascinu, Stefano; Offidani, A. | |
| A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors | 1-gen-2015 | de Braud, Filippo; Cascinu, S.; Spitaleri, G.; Pilz, K.; Clementi, L.; Liu, D.; Sikken, P.; De Pas, T. | |
| A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. | 1-gen-2012 | G., Gasparini; F., Torino; T., Ueno; Cascinu, Stefano; T., Troiani; A., Ballestrero; R., Berardi; J., Shishido; A., Yoshizawa; Y., Mori; S., Nagayama; P., Morosini; M., Toi | |
| A randomized, double blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel. | 1-gen-2013 | P., Maison Blanche; J. B., Vermorken; T., Goksel; J., Machiels; S., Agarwala; S., Rottey; G., Daugaard; C., Volovat; M., Scheulen; L., Sengeløv; D., Grecea; A., Eniu; E., Jäger; E., Meiri; Cascinu, Stefano; D., Strumberg; G., Demir; M., Clemens; G., Pinotti; M., Nardi; T., Guthrie; E., Boelle; E., Magherini | |
| A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC) | 1-gen-2019 | Salati, M.; Pipitone, S.; Rimini, M.; Gelsomino, F.; Casadei-Gardini, A.; Andrikou, K.; Schipilliti, F. M.; Cortesi, G.; Cassanelli, L.; Caffari, E.; Serra, F.; Ricciardolo, A.; De Ruvo, N.; Gelmini, R.; Cascinu, S.; Spallanzani, A. | |
| Adjuvant chemotherapy in colon cancer: can we improve quality of care? | 1-gen-2013 | Cascinu, Stefano | |
| Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. | 1-gen-2011 | Scartozzi, M.; Loretelli, C.; Bearzi, I.; Mandolesi, A.; Galizia, E.; Onofri, A.; Pistelli, M.; Bittoni, A.; Berardi, R.; Cascinu, Stefano | |
| Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. | 1-gen-2012 | M., Scartozzi; R., Giampieri; E., Maccaroni; A., Mandolesi; L., Giustini; R., Silva; A., Zaniboni; T., Biscotti; S., Biagetti; E., Galizia; F., Loupakis; A., Falcone; I., Bearzi; Cascinu, Stefano | |
| Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. | 1-gen-2014 | Pistelli, M; Caramanti, M; Biscotti, T; Santinelli, A; Pagliacci, A; De Lisa, M; Ballatore, Z; Ridolfi, F; Maccaroni, E; Bracci, R; Berardi, R; Battelli, N; Cascinu, Stefano | |
| Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue | 1-gen-2016 | Longo, Vito; Brunetti, Oronzo; Gnoni, Antonio; Cascinu, Stefano; Gasparini, Giampietro; Lorusso, Vito; Ribatti, Domenico; Silvestris, Nicola | |
| Angiogenetic pathway as a therapeutic target in renal cell carcinoma. | 1-gen-2012 | M., Bianconi; M., Scartozzi; L., Faloppi; A., Bittoni; E., Maccaroni; R., Giampieri; M. D., Prete; L., Burattini; Cascinu, Stefano | |
| ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib | 1-gen-2019 | Marisi, Giorgia; Petracci, Elisabetta; Raimondi, Francesco; Faloppi, Luca; Foschi, Francesco Giuseppe; Lauletta, Gianfranco; Iavarone, Massimo; Canale, Matteo; Valgiusti, Martina; Neri, Luca Maria; Ulivi, Paola; Orsi, Giulia; Rovesti, Giulia; Vukotic, Ranka; Conti, Fabio; Cucchetti, Alessandro; Ercolani, Giorgio; Andrikou, Kalliopi; Cascinu, Stefano; Scartozzi, Mario; Casadei-Gardini, Andrea | |
| Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials. | 1-gen-2013 | Iacovelli, R; Altavilla, A; Procopio, G; Bracarda, S; Santoni, M; Cascinu, Stefano; Cortesi, E. | |
| Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality | 1-gen-2019 | Malavasi, Vincenzo Livio; Fantecchi, Elisa; Gianolio, Laura; Pesce, Francesca; Longo, Giuseppe; Marietta, Marco; Cascinu, Stefano; Lip, Gregory Y. H.; Boriani, Giuseppe | |
| Bone metastases- Pharmacological treatment | 1-gen-2010 | Guarneri, Valentina; Bertolini, Federica; Cascinu, Stefano; T., Ibrahim | |
| BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival | 1-gen-2017 | Ponti, Giovanni; Manfredini, Marco; Greco, Stefano; Pellacani, Giovanni; Depenni, Roberta; Tomasi, Aldo; Maccaferri, Monia; Cascinu, Stefano |